Protara Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · New York, NY
TARA chart
What traders are saying about $TARA
Latest postsProtara Therapeutics, Inc. news
- Protara Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Weekly Recap: Third-quarter loss and THRIVE-3 enrollment completion
TradingView ·
- Protara Therapeutics (Nasdaq:TARA) - Stock Analysis
Simply Wall St ·
- Form 8K Protara Therapeutics Inc For: 6 November By Investing.com
Investing.com Nigeria ·
- Protara Therapeutics Stock Price Forecast. Should You Buy TARA?
StockInvest.us ·
- Protara Therapeutics, Inc. (TARA) Misses Q3 EPS by 1c
StreetInsider ·
- Protara Therapeutics, Inc. (1KPA.F) Seasonal returns chart
Yahoo Finance Australia ·
- Protara Therapeutics (TARA) Advances Late-Stage Trials, Eyes 202
GuruFocus ·
- Protara Therapeutics reports Q3 EPS (35c), consensus (36c)
TipRanks ·
- Protara Therapeutics Reports Q3 2026 Net Loss of $21.7 Million
TradingView ·
- Protara Therapeutics Q3 net loss widens on higher expenses
TradingView ·
- Protara Therapeutics: Q3 Earnings Snapshot
Yahoo Finance ·
Protara Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$57.4M | -$44.6M | -$40.4M | -$66.0M |
| Diluted EPS | $-1.34 | $-2.17 | $-3.57 | $-5.86 |
| Total assets (year end) | $209.5M | $181.5M | $79.0M | $113.3M |
| Cash and equivalents (year end) | $49.7M | $162.8M | $39.6M | $24.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 10-QQUARTERLY REPORT
- 8-KCURRENT REPORT
- 10-QQUARTERLY REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 10-QQUARTERLY REPORT
- 8-KCURRENT REPORT
- DEF 14APROXY STATEMENT
- 8-KCURRENT REPORT
- 10-KANNUAL REPORT
- 8-KCURRENT REPORT
About Protara Therapeutics, Inc.
- Ticker
- TARA (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- New York, NY
- Fiscal year end
- December 31
- SEC CIK
- 1359931
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
Frequently asked questions
What exchange is Protara Therapeutics, Inc. listed on?
Protara Therapeutics, Inc. trades on the Nasdaq under the ticker symbol TARA.
What industry is Protara Therapeutics, Inc. in?
Protara Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Protara Therapeutics, Inc. headquartered?
Protara Therapeutics, Inc.'s business address on file with the SEC is in New York, NY.
When does Protara Therapeutics, Inc.'s fiscal year end?
Protara Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Protara Therapeutics, Inc. report?
Protara Therapeutics, Inc. reported $2.9M in revenue for calendar year 2014, according to its SEC filings.